NASDAQ:LRCX   Lam Research Corporation
30th Nov - Retrace in Progress. At Fib level. On watch. Jan 210 Calls
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.